Lipoprotein alterations in patients with HIV infection:: relation with cellular and humoral immune markers

被引:32
作者
Fernández-Miranda, C [1 ]
Pulido, F
Carrillo, JL
Larumbe, S
Izquierdo, TG
Ortuño, B
Rubio, R
del Palacio, A
机构
[1] Hosp Univ 12 Octubre, Serv Internal Med, Madrid, Spain
[2] Hosp Univ 12 Octubre, Serv Biochem, Madrid, Spain
[3] Hosp Univ 12 Octubre, Nucl Med Serv, Madrid, Spain
关键词
HIV; lipoproteins; beta; 2-microglobulin; interferon-alpha; tumor necrosis factor-alpha; CD4 + lymphocytes;
D O I
10.1016/S0009-8981(98)00050-3
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
In order to determine lipid abnormalities in serum in HIV-infected patients and their relation with humoral and cellular immunological changes. Ninety HIV-infected patients without acute inflammatory or malignant disease have been studied. Thirty healthy HIV-negative subjects constituted the control group. As compared with controls, patients with CD4 + lymphocytes > 400 x 10(6)/l had higher triglycerides and lower high density lipoprotein (HDL)-cholesterol and apolipoprotein (apo)-Al. Lipoprotein comparison by groups of patients according to CD4 + cell counts showed a decrease of HDL-cholesterol in patients with CD4 + cells less than or equal to 200 X 10(6)/l.'Nhen CD4 + lymphocyte counts were < 50 X 10(6)/l, total and very low density lipoprotein (VLDL)triglycerides and VLDL-cholesterol were increased and HDL and low density lipoprotein (LDL)cholesterol and ape-Al were decreased. Interferon (IFN)-alpha, beta 2-microglobulin and tumor necrosis factor (TNF)-alpha were correlated positively with total and VLDL-triglycerides and negatively with HDL-cholesterol. Tn conclusion, lipoprotein changes in patients with HIV-infection are related with humoral and cellular immune markers. A decrease of HDL-cholesterol and ape-Al and an increase of triglyceride levels could be considered as markers of disease progression. (C) 1998 Elsevier Science B.V, All rights reserved.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 20 条
  • [1] ALVAREZ C, 1986, CLIN CHEM, V32, P142
  • [2] PLASMA-LIPIDS IN HIV-INFECTED PATIENTS - A PROSPECTIVE-STUDY IN 95 PATIENTS
    CONSTANS, J
    PELLEGRIN, JL
    PEUCHANT, E
    DUMON, MF
    PELLEGRIN, I
    SERGEANT, C
    SIMONOFF, M
    BROSSARD, G
    BARBEAU, P
    FLEURY, H
    CLERC, M
    LENG, B
    CONRI, C
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (06) : 416 - 420
  • [3] DEZUBE BJ, 1993, J ACQ IMMUN DEF SYND, V6, P787
  • [4] EDGINGTON TS, 1981, CANCER RES, V41, P3786
  • [5] FONTANALSFERRER N, 1988, CLIN CHEM, V34, P1753
  • [6] GRUNFELD C, 1992, P SOC EXP BIOL MED, V200, P224
  • [7] HYPERTRIGLYCERIDEMIA IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME
    GRUNFELD, C
    KOTLER, DP
    HAMADEH, R
    TIERNEY, A
    WANG, J
    PIERSON, RN
    [J]. AMERICAN JOURNAL OF MEDICINE, 1989, 86 (01) : 27 - 31
  • [8] LIPIDS, LIPOPROTEINS, TRIGLYCERIDE CLEARANCE, AND CYTOKINES IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    GRUNFELD, C
    PANG, MY
    DOERRLER, W
    SHIGENAGA, JK
    JENSEN, P
    FEINGOLD, KR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (05) : 1045 - 1052
  • [9] GRUNFELD C, 1991, AM J MED, V90, P154, DOI 10.1016/0002-9343(91)80154-E
  • [10] KROWN SE, 1991, J ACQ IMMUN DEF SYND, V4, P871